Welcome to our website. It's always a work in progress and your feedback is welcome



Petition to the European Parliament to:
Make funds available for trials and research for
LDN to achieve a licence and public availability


June 2012

Low-dose Naltrexone (LDN) has been used in the treatment of autoimmune diseases in the USA since 1985 with few initial side effects.

LDN is a cheap drug which can be prescribed on the NHS if the prescribing doctor thinks it's of benefit. However, many people have to obtain a private prescription and pay themselves.

There are lots of positive testimonials from patients using LDN for various conditions and therefore LDN could be helpful for many more people including those with autoimmune thyroid disease.

www.ldnnow.com are petitioning the European Parliament to make funding available, either directly through taxes or indirectly by directing research bodies to provide funding, to undergo trials for the generic drug, Low Dose Naltrexone (LDN).

If you are interested in signing this petition, please go to: